Amlodipine Besylate Tablet
Product Images NDC 42806-056

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 42806-056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine 10mg 1000ct (Amlodipine 10mg 90s)

Label for Amlodipine Besylate 10 mg oral tablets by Epic Pharma, LLC. The label displays the NDC 42806-057-10, specifies 1000 tablets in the package, and includes storage instructions, pharmacist dispensing note, and safety warnings. The label features the Epic Pharma logo and barcode.*

FDA Label Image

Amlodipine 2.5mg 90s

Packaging label for Amlodipine Besylate Tablets USP 2.5 mg by Epic Pharma, LLC. The label states the strength as 2.5 mg and includes storage instructions, dosage directions, a barcode, and a note that each tablet contains amlodipine besylate USP equivalent to 2.5 mg of amlodipine. The package contains 90 tablets and is designated Rx Only.*

FDA Label Image

Amlodipine 5mg 500ct (Amlodipine 5mg 90s)

Label for Amlodipine Besylate Tablets, USP 5 mg by Epic Pharma, LLC. The label indicates 500 tablets in the package, with storage instructions at 20° to 25°C and to keep tightly closed. It includes dosing directions reference, child-resistant closure notice, and safety warnings. The label features a barcode and the Epic Pharma logo.*

FDA Label Image

Effects-on-primary-endpoint-of-amlodipine (Effects On Primary Endpoint Of Amlodipine)

A forest plot depicting hazard ratios (with 95% confidence intervals) for various patient subgroups comparing Amlodipine versus placebo. Subgroups include all patients, age below and above 85, gender, baseline sitting systolic blood pressure, baseline vessel disease status, baseline vessels with stenosis, and PCI-stent status. The plot visually demonstrates relative risk favoring amlodipine or placebo across these groups.*

FDA Label Image

Kaplan-meier-analysis (Kaplan Meier Analysis)

A Kaplan-Meier event rate curve comparing Amlodipine and Placebo groups over time in months. The graph shows event rates on the y-axis and time from 0 to 24 months on the x-axis, with annotations for p-value, hazard ratio, and 95% confidence interval.*

FDA Label Image

Structural Formula

Chemical structure of amlodipine besylate depicting its molecular composition with labeled atoms and bonds, including chlorine, oxygen, nitrogen, and methyl groups as part of the dihydropyridine class.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.